Search results
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 3 hours agocompany also reported sales growth of 36 percent in 2023. Novo’s market value is now greater than...
Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
KFDX Wichita Falls· 2 hours agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 14 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar ...
IP Risks from AI’s Role In Drug Discovery | Law.com
Law.com· 3 hours agoOne study found that the number of startup drug candidate pipelines employing AI is roughly equivalent to 50% of the preclinical programs of big ...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 2 days agoThe majority of the large drugmakers...over year. Here we discuss five drug/generic companies,...
Earnings call: X4 Pharmaceuticals reports Q1 2024 results and drug developments By Investing.com
Investing.com· 1 day agoX4 Pharmaceuticals (NASDAQ:XFOR) has announced its financial results for the first quarter of 2024...
The FTC is challenging 'junk' drug patents. Here's what they are and why they matter
Quartz· 2 hours agoThe U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time,...
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
Reuters· 1 day ago, opens new tab reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales ...
Inside Madrigal's 'full speed' launch of its groundbreaking NASHdrug Rezdiffra - Philadelphia...
The Business Journals· 6 hours agoIn the seven weeks since Madrigal Pharmaceuticals became the first drug developer to receive Food...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 14 hours agoAlpine acquisition In addition to developing new drug candidates internally, Vertex's CF profits...